Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH

Cellular immunotherapy has recently emerged as a fourth pillar in cancer treatment co-joining surgery, chemotherapy and radiotherapy. Where, the discovery of immune checkpoint blockage or inhibition (ICB/ICI), anti-PD-1/PD-L1 and anti-CTLA4-based, therapy has revolutionized the class of cancer treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sunil, Sarthi, Parth, Mani, Indra, Ashraf, Muhammad Umer, Kang, Myeong-Ho, Kumar, Vishal, Bae, Yong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466810/
https://www.ncbi.nlm.nih.gov/pubmed/34571899
http://dx.doi.org/10.3390/cells10092250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466810/
https://www.ncbi.nlm.nih.gov/pubmed/34571899
http://dx.doi.org/10.3390/cells10092250

Ejemplares similares